Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|May 6, 2025
Applying the Principal Stratum Strategy in Equivalence Trials: A Case StudyJerome Sepin, Thomas P A Debray, Wei Wei, et al.
Drug Safety|March 23, 2011
Today's challenges in pharmacovigilance: what can we learn from epoetins?Hans C Ebbers, Aukje K Mantel-Teeuwisse, Ellen H M Moors, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 24, 2015
Licensing failure in the European decentralised procedureJoris Langedijk, Hans C Ebbers, Aukje K Mantel-Teeuwisse, et al.
Ophthalmology and Therapy|March 12, 2022
An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative ReviewSeenu M Hariprasad, Richard P Gale, Christina Y Weng, et al.
Rheumatology and Therapy|April 8, 2025
A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference ProductHans C Ebbers, Peter C Taylor, Xiaomei Leng, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 13, 2013
Differences between post-authorization adverse drug reactions of biopharmaceuticals and small moleculesHans C Ebbers, Esraa Al-Temimi, Ellen H M Moors, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 18, 2024
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference TocilizumabYujie Liu, Jianhua Xie, Zhuxiang Li, et al.
Drug Safety|April 18, 2012
A cohort study exploring determinants of safety-related regulatory actions for biopharmaceuticalsHans C Ebbers, Aukje K Mantel-Teeuwisse, Ellen H M Moors, et al.
European Journal of Clinical Pharmacology|June 19, 2012
The role of Periodic Safety Update Reports in the safety management of biopharmaceuticalsHans C Ebbers, Aukje K Mantel-Teeuwisse, Fakhredin A Sayed-Tabatabaei, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 6, 2025
Comparative Structure Activity Relationship Characterization of the Biosimilar BAT1806/BIIB800 to Reference TocilizumabYujie Liu, Jianhua Xie, Zhuxiang Li, et al.
Pageof 3